We found that MTA1 overexpression results in a marked reduction in the level of DNMT3a, while MTA1 silencing leads to an increased DNMT3a expression in breast cancer MCF-7 and SKBR-3 cells (Fig. 2A,B). This evidence concerns the gene DNMT3A and breast carcinoma.